Human clinical trial for the efficacy of A (Centella serum) in improving wrinkles and whitening after 4 weeks use.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011676

Enrollment

Registered

2026-03-04

Start date

2024-09-04

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(A (Centella serum) and B (General serum) comparison) : In this study, the face of the test subject was vertically divided into halves

one side was designated as a test group, which the test product (Centella asiatica serum) was applied to, while the other one was designated as a control group, which the control product (normal serum

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Healthy Korean female and male adult over the age of 30 - Subjects who have signed consent form voluntarily after being informed sufficiently on the objectives of study and all related contents - Subjects who are healthy without acute and chronic diseases, including skin disorders - Subjects who can be observed and traced throughout the entire study period

Exclusion criteria

Exclusion criteria: - Subjects who are and/or have plan for pregnancy or breastfeeding - Subjects who have psychiatric disease and infectious skin disease - Subjects who have used an ointment containing steroids for more than 1 month - Subjects who participated in the similar test within the past 6 months - Subjects who have sensitive and hypersensitive skin - Subjects who have skin disorders on the test site, such as moles, pimples, red spots, scalds (burns), hemotelangiosis, and scars - Subjects who have used cosmetics or drugs on the test site with similar efficacy within in the past 3 months - Subjects who received treatment from dermatologist or aestheticians on the test site within the past 6 months - Those who are employed in this clinical trial center - Those who are considered as a nonqualified person by judge or the investigator

Design outcomes

Primary

Measure	Time frame
wrinkles (eye area);whitening	—

Secondary

Measure	Time frame
Efficacy self report questionnaire;Assessment of s kin adverse reaction	—

Countries

Korea, Republic of

Contacts

Public ContactKim Dahyeon

Human Co., Ltd. Skin Clinical Trial Center

ekgus0599@daum.net+82-70-6741-0376

Outcome results